US Broker Ratings

GSK plc (GSK) Stock Analysis: Navigating a Strong Dividend Yield Amidst a Conservative Growth Outlook

Investors eyeing the healthcare sector may find GSK plc (NYSE: GSK) an intriguing proposition, especially given its strong dividend yield and its steadfast presence in the..

CVS Health Corporation (CVS) Investor Outlook: Strong Buy Ratings and 14% Potential Upside

CVS Health Corporation (NYSE: CVS), a leading player in the healthcare sector, presents a compelling investment opportunity with its robust market position and significant growth potential...

Summit Therapeutics Inc. (SMMT): Analyst Consensus Reveals 27% Upside Potential in Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a leader in the biotechnology sector, is capturing the attention of investors with its promising potential for growth and innovation in..

Exact Sciences Corporation (EXAS) Stock Analysis: A 32.65% Potential Upside Grabs Investor Attention

Exact Sciences Corporation (NASDAQ: EXAS) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. Boasting a market capitalization of..

Genmab A/S (GMAB) Stock Analysis: A Biotech Leader with a 23.99% Upside Potential

Genmab A/S (NASDAQ: GMAB), a pioneering biotechnology company based in Denmark, has been capturing the attention of investors due to its robust pipeline of innovative therapies..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Strong Upside Potential of 21.89%

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector with a robust market capitalization of $14.12 billion. Specializing in the development of therapies for..

Natera, Inc. (NTRA) Stock Analysis: Understanding the 19.44% Upside Potential and Analyst Confidence

Natera, Inc. (NTRA), a key player in the healthcare sector specializing in diagnostics and research, is garnering significant attention from investors. With a market capitalization of..

Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential with a 12.55% Upside in Biotech

Insmed Incorporated (NASDAQ: INSM) is capturing the attention of investors due to its significant presence in the biotechnology sector, a market cap of $27.88 billion, and..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating the 10.07% Potential Upside

Illumina, Inc. (ILMN), a leading player in the healthcare sector’s diagnostics and research industry, presents an intriguing investment opportunity. With a market cap of $16.11 billion,..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with Potential Upside and Impressive Revenue Growth

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in innovative medical devices that have revolutionized insulin delivery systems. The company’s Omnipod platform..

Quest Diagnostics (DGX) Investor Outlook: Analyzing a 4.42% Potential Upside in the Healthcare Sector

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specializes in diagnostic testing and services, providing a broad spectrum of diagnostic information services..

Danaher Corporation (DHR) Stock Analysis: Unpacking a 16.12% Upside Potential with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a leading player in the healthcare sector, specializes in diagnostics and research. With a substantial market capitalization of $151.66 billion, Danaher is..

Humana Inc. (HUM) Investor Outlook: Evaluating the Healthcare Giant with a $36 Billion Market Cap

Investors in the healthcare sector frequently look to Humana Inc. (NYSE: HUM) as a stalwart with a solid reputation for delivering comprehensive healthcare plans in the..

Labcorp Holdings Inc. (LH) Stock Analysis: A Healthcare Giant with a 5.60% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, has carved out a significant niche in the diagnostics and research industry. With a..

Hologic, Inc. (HOLX) Stock Analysis: Exploring the 7.53% Potential Upside for Healthcare Investors

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust portfolio in diagnostics and medical..

Alcon Inc. (ALC) Stock Analysis: Exploring an 18.99% Potential Upside

Alcon Inc. (NYSE: ALC), a global leader in eye care products, presents an intriguing opportunity for investors looking to venture into the healthcare sector. As a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Deep Dive into Potential Upside and Analyst Ratings

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector and a leading player in the specialty and generic drug manufacturing industry, offers a compelling..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with a 6.18% Upside Potential

Medtronic plc (MDT), a cornerstone in the healthcare sector, is making waves with its solid market presence and promising growth potential. With a market capitalization of..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 21.49% Potential Upside in Animal Health Investments

Zoetis Inc. (NYSE: ZTS) stands out as a pivotal player in the healthcare sector, particularly within the specialized niche of animal health. With an impressive market..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Medical Devices Market with a 2.98% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking exposure to..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds